Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the control of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://louisetmuq989726.eedblog.com/39237948/retaglutide-a-promising-glp-1-receptor-agonist